Drawing for GENEXTRA

USPTO serial 79001852

GENEXTRA

Reviewed by CopyMark Law Group

Reg. 3100889Status 404
Filing date
Status date
Registration date
Jun 6, 2006
Examiner
AIKENS, RONALD E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENEXTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JEFFREY H KAUFMAN

JEFFREY H KAUFMAN OBLON SPIVAK MCCLELLAND MAIER & NEUSTADT1940 DUKE STALEXANDRIA, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in the pharmacological, biotechnology and medical industries, namely, chemicals used in the manufacture of pharmaceuticals used to treat diseases related to tumors, the nervous system, aging, infection, the immune system, the heart and cardiovascular system, the muscle system, mental illness, the respiratory system, and the digestive systemSECTION 71 - CANCELLED—
003Cleaning, polishing, scouring and abrasive liquids and powders; soaps, perfumery, essential oils, cosmetics, hair lotions; dentrifricesSECTION 71 - CANCELLED—
005Pharmaceutical, veterinary and sanitary products, namely, chemical preparations; dietetic substances adapted for medical use, namely, food for babies; medical plasters, chemical, biochemical, biological and biotechnological preparations for medical, clinical, pharmaceutical or veterinary purposes; diagnostic products,namely, test strips, and preparations for use in detecting, scanning and analyzing disease-related gene mutationsSECTION 71 - CANCELLED—
042Technical research and development and consultation related to biotechnological, pharmacological, molecular/cellular medicine, genetic and diagnostic research for clinical, therapeutic, prophylactic and diagnostic applications and procedures; analysis and industrial research servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2014DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Sep 18, 2014DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 16, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 29, 2014INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 11, 2013INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 11, 2013C71TCANCELLED SECTION 71—
Dec 6, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 17, 2007FIXDELECTRONIC RECORD REVIEW COMPLETE—
Feb 5, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 5, 2007FIMPFINAL DISPOSITION PROCESSED—
Jan 24, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 6, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2006NPUBNOTICE OF PUBLICATION—
Dec 14, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 9, 2005ALIEASSIGNED TO LIE—
Dec 6, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 6, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 16, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2005MAILPAPER RECEIVED—
Oct 13, 2005OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 29, 2005OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 29, 2005OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 16, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 4, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2005MAILPAPER RECEIVED—
Feb 24, 2005CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 14, 2004RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2004DOCKASSIGNED TO EXAMINER—
May 3, 2004NWAPNEW APPLICATION ENTERED—
Apr 29, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance